Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation

NCT02232880 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped failure to recruit

Conditions

Hypertension

Interventions

DRUG: Abatacept
DRUG: Placebo

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]